Professional Documents
Culture Documents
You raised series A venture capital last year when your company was valued at $30 million. Now, you need to
raise the series B, but the investors tell you that your company is only worth $20 million. What does this mean
you? And, what is the effect of the "Anti-dilition Provision" in the series A investors' Term Sheet?
This workbook will calculate how much common shareholders will be diluted in the series B venture financing
(preferred stock) which is priced lower than the first round venture financing.
You can see the dilution where the series A financing provides for 2 scenarios: Simple Scenario and Normal
Scenario. In the aimple scenario, you know the purchase price and shares number for Series B investor. But this
is not the normal scenario, where you only know the pre-money valuation and the investment amount for the
Series B investor. In each scenario, there are there situations:
1 - no adjustment to the conversion price
2 - partial adjustment to the conversion price: (Broad-based weighted average & Narrow-based weighted
average)
3 - full adjustment of the conversion price: (Full ratched)
Just fill in the highlighted assumptions on the worksheet -- 'Assumptions and Results'.
Company Ownership
Before Non Weighted Average
Series B anti-dilution Broad based
Common share 80.00% 72.73% 72.10%
Series A investor 20.00% 18.18% 18.88%
Series B investor 0.00% 9.09% 9.01%
Normal Scenario
Assumptions
Founder's Common share 8,000,000
Series A Investment $2,000,000
Series A Preferred share % 20.00%
Series B Investment $8,000,000
Series B Pre-money Valuation $8,000,000
Company Ownership
Before Non Weighted Average
Series B anti-dilution Broad based
Common share 80.00% 40.00% 39.02%
Series A investor 20.00% 10.00% 10.98%
Series B investor 0.00% 50.00% 50.00%
Non anti-dilution
Common share 40,000,000
Series A Conversion Price $1.00
Series A Common share on As-converted Base 10,000,000
Series B Conversion Price $0.50
Series B Common share on As-converted Base 5,000,000
Total Fully Diluted Shares 55,000,000
Series B Post-money Valuation 27,500,000
Shared between:
Founder's value lost -20,000,000
% 80.00%
Series A investor's value lost -5,000,000
% 20.00%
% Ownership
80.00%
20.00%
100.00%
72.73%
18.18%
9.09%
100.00%
72.10%
OP ∗ ( FS + AS ) + BI
WP =
18.88% FS + AS + BS
9.01%
100.00%
70.18%
AI + BI
WP =
21.05% AS + BS
8.77%
100.00%
61.54%
30.77%
7.69%
100.00%
Weighted Average Full Ratchet
Broad based Narrow based anti-dilution
50,000,000 50,000,000 50,000,000
25,238,095 26,000,000 30,000,000
-24,761,905 -24,000,000 -20,000,000
% Ownership
Before Series B Financing
Founder's Share 8,000,000 80.00%
Series A Conversion Price $1.00
Series A Common share on As-converted Base 2,000,000 20.00%
Total Fully Diluted Shares 10,000,000 100.00%
Non anti-dilution
Common share 8,000,000 40.00%
Series A Conversion Price $1.00
Series A Common share on As-converted Base 2,000,000 10.00%
Total Fully Diluted Shares Before Series B 10,000,000
Series B Pre-money Valuation $8,000,000
Series B Investment $8,000,000
Series B shares 10,000,000 50.00%
NP Series B Purchase Price $0.80
Total Fully Diluted Shares 20,000,000 100.00%
Shared between:
Founder's value lost -1,600,000 -1,756,098 -1,904,762 -2,000,000
% 80.00% 87.80% 95.24% 100.00%
Series A investor's value lost -400,000 -243,902 -95,238 0
% 20.00% 12.20% 4.76% 0.00%